Blog

Nitroso-group impurities, often encountered as nitrosamine residual impurities, are characterized by the presence of a nitroso (–N=O) functional group and may form unintentionally during synthesis, processing, or storage of pharmaceutical and chemical products.

Nitrosamine trace impurities belong to a defined nitrosamine chemical grouping within the broader nitrosamine impurity family and can arise as nitrosamine impurity formation products during pharmaceutical manufacturing, processing, or storage.

Nitrosamine excipient risk refers to the potential formation or presence of nitrosamine molecules, including tertiary nitrosamine species and volatile nitroso compounds, within pharmaceutical excipients.

Nitrosamine compounds are a critical quality concern because many are potentially carcinogenic and can be harmful even at very low levels, making their control essential in pharmaceuticals

Nitrosamine-class chemicals are organic substances containing a nitroso (–N–N=O) group bonded to an amine.

Nitrosamine degradation products are formed when unstable N-nitroso compoundsbreak down in pharmaceutical formulations or environmental matrices

Nitrosamine degradation products are formed when unstable N-nitroso compoundsbreak down in pharmaceutical formulations or environmental matrices

The risk evaluation of nitrosated agents centers on nitrosamines, which belong to a high-risk nitrosamine chemical hazard class and are widely recognized as genotoxic impurities due to their DNA-damaging and carcinogenic potential.

Embryo-fetal toxicity refers to harmful effects on a developing embryo or fetus due to exposure to certain substances, such as medications, chemicals, or environmental factors.

Fluid retention, also known as water retention, occurs when excess fluid builds up in the body's tissues, causing swelling often in the hands, feet, ankles, or legs.